Clinical Trial Update: PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer [EARLY_Phase 1]

View source ↗

Summary

Clinical trial update for PSMA and C-11 Choline PET in patients with biochemical recurrence of prostate cancer; the EARLY Phase 1 study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-PSMA-11 (Gallium-68 labeled PSMA-11 radiopharmaceutical)
• C-11 Choline (Carbon-11 choline)

Snippet

Sponsor: Mayo Clinic | Conditions: Prostate Cancer | EARLY_Phase 1 | Status: COMPLETED